Lung cancer: open trials in Colombia

23 open trials have a site in Colombia. Registry data; only the trial team decides who can take part.

NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
Centro Cancerologico del Caribe LTDA CECAC, Barranquilla · Centro de Tratamiento e Investigación sobre Cancer Luis Carlos Sarmiento Angulo Ctic, Bogota · Instituto Nacional de Cancerologia, Bogota · Fundacion cardiovascular de Colombia, Bucaramanga · Hemato Oncologos SA, Cali · Fundacion Colombiana de Cancerologia Clinica Vida, Medellín · Instituto Medico de Alta Tecnologia sas - Imat sas, Montería · Oncologos del Occidente SAS, Pereira · Sociedad de Oncologia y Hematologia del Cesar, Valledupar
Registry updated 2026-11-06
NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO (Site 0600), Bogotá · IMAT S.A.S (Site 0602), Montería · Oncologos del Occidente (Site 0603), Pereira
Registry updated 2026-11-03
NCT07431827
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO (Site 0601), Bogota · Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia (Site 0603), Bogotá · Promotora Médica Las Américas S.A. (Site 0602), Medellín · Instituto Médico de Alta Tecnología S.A.S. (Site 0605), Montería · Oncologos Del Occidente (Site 0606), Pereira
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Local Institution - 007-467, Bogotá · Local Institution - 007-465, Floridablanca · Local Institution - Unk021, Medellín · Local Institution - Unk027, Montería · Local Institution - 007-466, Valledupar
Registry updated 2026-10-30
NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Universitario San Ignacio (Site 2610), Bogotá · Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia (Site 2604), Bogotá · FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO (Site 2603), Bogotá · Fundacion Valle del Lili- CIC (Site 2601), Cali · IMAT S.A.S (Site 2602), Montería · Oncologos del Occidente (Site 2608), Pereira
Registry updated 2026-10-30
NCT07513376
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Instituto Nacional De Cancerologia-Oncología Clínica (Site 3804), Bogota · Clínica Universitaria Colombia (Site 3803), Bogotá · FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO (Site 3806), Bogotá · Promotora Médica Las Américas S.A. (Site 3800), Medellín · Instituto Médico de Alta Tecnología S.A.S - IMAT S.A.S (Site 3801), Montería · Clinica Somer (Site 3802), Rionegro
Registry updated 2026-10-30
NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AbbVie
Fundacion Ctic - Centro De Tratamiento E Investigacion Sobre Cancer Luis Carlos /ID# 258131, Bogotá · Hospital Pablo Tobon Uribe /ID# 258128, Medellín · Imat Oncomedica /ID# 258129, Montería · Sociedad de Oncologia y Hematologia del Cesar SAS /ID# 258130, Valledupar
Registry updated 2026-10-29
NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Centro Cancerológico del Caribe (CECAC) (Site 0509), Barranquilla · FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO (Site 0500), Bogotá · Fundación Valle del Lili-Oncology CIC (Site 0505), Cali · Oncologos del Occidente (Site 0504), Pereira · Sociedad De Oncología y Hematología Del Cesar SAS-Oncology (Site 0501), Valledupar
Registry updated 2026-10-29
NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Trial Treatment · Phase 3 · Mirati Therapeutics Inc.
Fundación Valle del Lili, Cali · Fundación Cardiovascular de Colombia, Floridablanca · Clinica Medellin S.A, Medellín · Instituto Médico de Alta Tecnología S.A.S - IMAT S.A.S, Montería · Clinica Somer, Rionegro · Sociedad De Oncología y Hematología Del Cesar SAS, Valledupar
Registry updated 2026-10-27
NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Clinica Oncologica Colsubsidio (Site 4003), Bogota · Hemato Oncologos SA (Site 4002), Cali · Oncologos del Occidente (Site 4005), Pereira · Sociedad De Oncología y Hematología Del Cesar SAS (Site 4000), Valledupar
Registry updated 2026-10-26
NCT07190248
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia (Site 0607), Bogotá · Hospital Universitario San Ignacio (Site 0604), Bogotá · Promotora Médica Las Américas S.A. (Site 0608), Medellín
Registry updated 2026-10-26
NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Hospital Universitario San Ignacio, Bogotá · Bogotá · Cali · Instituto de Cancerología, Medellín · Oncologos del Occidente, Pereira · Valledupar
Registry updated 2026-10-23
NCT07063745
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Bogotá · Medellín · Montería
Registry updated 2026-10-23
NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Barranquilla · Bogotá · Bogotá · Medellín · Rionegro
Registry updated 2026-10-23
NCT07541170
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogota, D.C. · Clinica ASTORGA, Medellín
Registry updated 2026-10-13
NCT07100080
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Bogotá · Cali · Montería · Valledupar
Registry updated 2026-10-09
NCT06868277
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · AstraZeneca
Cali · Floridablanca · Medellín · Valledupar
Registry updated 2026-09-25
NCT07816263
Guaraná Supplementation for Cancer-Related Fatigue
Research · Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Fundación CTIC Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogotá
Registry updated 2026-09-11
NCT07741435
Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia
Research · Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Fundación CTIC Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogotá
Registry updated 2026-08-03
NCT07703631
Characterization, Health Resource Utilization and Biomarkers in Early-stage
Research · Hospital Universitario San Ignacio
Hospital Universitario San Ignacio, Bogotá
Registry updated 2026-07-14
NCT07633626
Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib
Research · Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Centro de Tratamiento e Investigación sobre Cancer Luis Carlos Sarmiento Angulo Ctic, Bogota
Registry updated 2026-06-08
NCT07524803
Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)
Research · Latin American Consortium for the Lung Cancer Research
CTIC, Bogotá
Registry updated 2026-04-13
NCT05998993
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)
Trial Treatment · Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo, Bogotá
Registry updated 2023-08-21

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error